These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 10095017)

  • 1. Discriminant power of combined cerebrospinal fluid tau protein and of the soluble interleukin-6 receptor complex in the diagnosis of Alzheimer's disease.
    Hampel H; Teipel SJ; Padberg F; Haslinger A; Riemenschneider M; Schwarz MJ; Kötter HU; Scheloske M; Buch K; Stübner S; Dukoff R; Lasser R; Müller N; Sunderland T; Rapoport SI; Möller HJ
    Brain Res; 1999 Mar; 823(1-2):104-12. PubMed ID: 10095017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-6 (IL-6) and soluble forms of IL-6 receptors are not altered in cerebrospinal fluid of Alzheimer's disease patients.
    März P; Heese K; Hock C; Golombowski S; Müller-Spahn F; Rose-John S; Otten U
    Neurosci Lett; 1997 Dec; 239(1):29-32. PubMed ID: 9547164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined assessment of tau and neuronal thread protein in Alzheimer's disease CSF.
    Kahle PJ; Jakowec M; Teipel SJ; Hampel H; Petzinger GM; Di Monte DA; Silverberg GD; Möller HJ; Yesavage JA; Tinklenberg JR; Shooter EM; Murphy GM
    Neurology; 2000 Apr; 54(7):1498-504. PubMed ID: 10751266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased soluble interleukin-6 receptor in cerebrospinal fluid of patients with Alzheimer's disease.
    Hampel H; Sunderland T; Kötter HU; Schneider C; Teipel SJ; Padberg F; Dukoff R; Levy J; Möller HJ
    Brain Res; 1998 Jan; 780(2):356-9. PubMed ID: 9507194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study.
    Hampel H; Buerger K; Zinkowski R; Teipel SJ; Goernitz A; Andreasen N; Sjoegren M; DeBernardis J; Kerkman D; Ishiguro K; Ohno H; Vanmechelen E; Vanderstichele H; McCulloch C; Moller HJ; Davies P; Blennow K
    Arch Gen Psychiatry; 2004 Jan; 61(1):95-102. PubMed ID: 14706948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-6 and the soluble IL-6 receptor are decreased in cerebrospinal fluid of geriatric patients with major depression: no alteration of soluble gp130.
    Stübner S; Schön T; Padberg F; Teipel SJ; Schwarz MJ; Haslinger A; Buch K; Dukoff R; Lasser R; Müller N; Sunderland T; Rapoport SI; Möller HJ; Hampel H
    Neurosci Lett; 1999 Jan; 259(3):145-8. PubMed ID: 10025579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CSF markers in Alzheimer disease patients are not related to the different degree of cognitive impairment.
    Stefani A; Martorana A; Bernardini S; Panella M; Mercati F; Orlacchio A; Pierantozzi M
    J Neurol Sci; 2006 Dec; 251(1-2):124-8. PubMed ID: 17097109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-6 transsignaling: the in vivo consequences.
    Jones SA; Richards PJ; Scheller J; Rose-John S
    J Interferon Cytokine Res; 2005 May; 25(5):241-53. PubMed ID: 15871661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CSF beta-amyloid 1-42 and tau in Tunisian patients with Alzheimer's disease: the effect of APOE epsilon4 allele.
    Smach MA; Charfeddine B; Lammouchi T; Harrabi I; Ben Othman L; Dridi H; Bennamou S; Limem K
    Neurosci Lett; 2008 Aug; 440(2):145-9. PubMed ID: 18555606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous analysis of cerebrospinal fluid biomarkers using microsphere-based xMAP multiplex technology for early detection of Alzheimer's disease.
    Kang JH; Vanderstichele H; Trojanowski JQ; Shaw LM
    Methods; 2012 Apr; 56(4):484-93. PubMed ID: 22503777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer's disease.
    Heslegrave A; Heywood W; Paterson R; Magdalinou N; Svensson J; Johansson P; Öhrfelt A; Blennow K; Hardy J; Schott J; Mills K; Zetterberg H
    Mol Neurodegener; 2016 Jan; 11():3. PubMed ID: 26754172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms of the gene encoding the inflammatory cytokine interleukin-6 determine the magnitude of the increase in soluble interleukin-6 receptor levels in Alzheimer's disease. Results of a pilot study.
    Bagli M; Papassotiropoulos A; Hampel H; Becker K; Jessen F; Bürger K; Ptok U; Rao ML; Möller HJ; Maier W; Heun R
    Eur Arch Psychiatry Clin Neurosci; 2003 Feb; 253(1):44-8. PubMed ID: 12664314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pattern of interleukin-6 receptor complex immunoreactivity between cortical regions of rapid autopsy normal and Alzheimer's disease brain.
    Hampel H; Haslinger A; Scheloske M; Padberg F; Fischer P; Unger J; Teipel SJ; Neumann M; Rosenberg C; Oshida R; Hulette C; Pongratz D; Ewers M; Kretzschmar HA; Möller HJ
    Eur Arch Psychiatry Clin Neurosci; 2005 Aug; 255(4):269-78. PubMed ID: 15565298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tau in cerebrospinal fluid: a potential diagnostic marker in Alzheimer's disease.
    Arai H; Terajima M; Miura M; Higuchi S; Muramatsu T; Machida N; Seiki H; Takase S; Clark CM; Lee VM
    Ann Neurol; 1995 Oct; 38(4):649-52. PubMed ID: 7574462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Soluble IL-6 receptors].
    Jabłońska E
    Postepy Hig Med Dosw; 1998; 52(2):133-8. PubMed ID: 9640977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand.
    Thaweepoksomboon J; Senanarong V; Poungvarin N; Chakorn T; Siwasariyanon N; Washirutmangkur L; Udompunthuruk S
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S77-83. PubMed ID: 21721431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [CSF levels of total tau protein in patients with mild cognitive impairment and Alzheimer's disease].
    Kaiser E; Schönknecht P; Hunt A; Thomann PA; Pantel J; Schröder J
    Z Gerontol Geriatr; 2008 Dec; 41(6):497-501. PubMed ID: 18327693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid tau and beta-amyloid in Alzheimer patients, disease controls and an age-matched random sample.
    Ibach B; Binder H; Dragon M; Poljansky S; Haen E; Schmitz E; Koch H; Putzhammer A; Kluenemann H; Wieland W; Hajak G
    Neurobiol Aging; 2006 Sep; 27(9):1202-11. PubMed ID: 16085339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The N-terminus of gp130 is critical for the formation of the high-affinity interleukin-6 receptor complex.
    Moritz RL; Ward LD; Tu GF; Fabri LJ; Ji H; Yasukawa K; Simpson RJ
    Growth Factors; 1999; 16(4):265-78. PubMed ID: 10427501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signal through gp130 activated by soluble interleukin (IL)-6 receptor (R) and IL-6 or IL-6R/IL-6 fusion protein enhances ex vivo expansion of human peripheral blood-derived hematopoietic progenitors.
    Kimura T; Wang J; Minamiguchi H; Fujiki H; Harada S; Okuda K; Kaneko H; Yokota S; Yasukawa K; Abe T; Sonoda Y
    Stem Cells; 2000; 18(6):444-52. PubMed ID: 11072033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.